< Go Back

Zenith Epigenetics Appoints Julie Cherrington as President and CEO Spanish
AbbVie to Host Second-Quarter Earnings Conference Call
MSC and Cape Regional Medical Center Partner to Improve Cost, Quality and Outcomes
MedNet Appoints Clareece West As Chief Operating Officer
SonoSim LiveScan™ injects stark realism into medical simulation
Dotmatics Announce Speaker Line-up for User Group Meeting 2014
RVX-208 Reduces Major Adverse Cardiovascular Events (MACE) Significantly in Patients with Diabetes Mellitus English
Mezzion Pharma Initiates Clinical Development Program To Evaluate Udenafil In Adolescents With Single Ventricle Heart Defects
Valentis Nanotech Signs MOU to Integrate Technology in Thermoplastics Production
Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse
Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures
BioAmber announces exercise in full of underwriters' option in connection with previously priced follow-on offering
MiMedx Files Its Initial Investigational New Drug Application
GrowBLOX Sciences, Inc. Files for Two Additional Medical Marijuana Dispensaries in Las Vegas
Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen
ArmaGen Announces Strategic Licensing and Collaboration Agreement with Shire to Develop AGT-182 for Treatment of Hunter Syndrome
Essentialis Secures Foundation for Prader-Willi Research Grant to Help Advance DCCR in the Treatment of Prader-Willi Syndrome
Sofinnova Raises $500 Million Biotech Venture Fund
China Cord Blood Corporation and Cordlife Group Limited Announce Collaboration to Aid Asia-based Patients with Cord Blood Stem Cell Therapy
Taiho Pharmaceutical Invests US$30 Million in Remiges BioPharma Fund, LP
Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets
Restrospective Analysis Finds MiMedx EpiFix® As Most Effective In Rapid Resolution Of Diabetic Foot Ulcers When Compared With Two Other Skin Substitutes
Jazz Pharmaceuticals to Report 2014 Second Quarter Financial Results on August 5, 2014 English
BD Board Declares Dividend
Cumberland Pharmaceuticals To Announce Second Quarter 2014 Financial Results On August 5, 2014
Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018
Dr. Neal Rouzier Joins BioTE Medical
Particle Sciences and Eyeon Therapeutics Receive Patent on Novel Dry Eye Technology
BiologicTx Paired Donation Aids In Successful Kidney Transplants
Pullman Regional Hospital changes more than 1,100 touch points to Hussey Copper's MD-Cu29 antimicrobial copper to help protect against bacteria
BGI Tech Launches Human Whole Exome Sequencing Service on Complete Genomics' Advanced Platform
Galmed Announces FDA Clearance of IND of Armachol for the Treatment of Fatty Liver Disorders
Neodyne Biosciences, Inc., Manufacturer of embrace® Advanced Scar Therapy, Receives Notice of Allowance for Korean Patent
Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer
Neogen reports 19% increase in annual revenues
Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices
BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors
Semler to Report Second Quarter 2014 Financial Results and Host Conference Call on July 25, 2014
ConvaTec Names Nigel Clerkin Chief Financial Officer English
Sequenom Laboratories Presents New Data on the Enhanced Sequencing Series for the MaterniT21™ Plus Laboratory-Developed Test At 18th International Conference on Prenatal Diagnosis and Therapy English
$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research
United Therapeutics Corporation To Announce Second Quarter 2014 Financial Results Before Market Open On Tuesday, July 29, 2014
Quantum Materials Announces New Outside Directors and Adds Scientific Advisory Board
Glide Pharma Completes Successful Proof-of-Concept Study with Novel Solid Dose Formulation of Octreotide
Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Thursday, July 24
EHE International Certifies Dignity Health Medical Group Nevada, LLC as Its Newest Partner
ADB International Group Inc. Announces Partnership with Austen BioInnovation Institute to Bring E-QURE BST™ Wound Healing Device to U.S. Market
Cynthia Fleck to Lead Marketing and Clinical Resource Development for Viniferamine® Medical Skin and Wound Care Products
Biosimilars/Follow-on-Biologics Market is Expected to Reach $35 Billion, Globally, by 2020
Local Southern California Medical Technology Event Draws Big Name Speakers

< Prev Next >
PR Newswire - United Business Media